Williams, Ross D.
Markus, Aniek F.
Yang, Cynthia
Duarte-Salles, Talita
DuVall, Scott L.
Falconer, Thomas
Jonnagaddala, Jitendra
Kim, Chungsoo
Rho, Yeunsook
Williams, Andrew E.
Machado, Amanda Alberga
An, Min Ho
Aragón, María
Areia, Carlos
Burn, Edward
Choi, Young Hwa
Drakos, Iannis
Abrahão, Maria Tereza Fernandes
Fernández-Bertolín, Sergio
Hripcsak, George
Kaas-Hansen, Benjamin Skov
Kandukuri, Prasanna L.
Kors, Jan A.
Kostka, Kristin
Liaw, Siaw-Teng
Lynch, Kristine E.
Machnicki, Gerardo
Matheny, Michael E.
Morales, Daniel
Nyberg, Fredrik
Park, Rae Woong
Prats-Uribe, Albert
Pratt, Nicole
Rao, Gowtham
Reich, Christian G.
Rivera, Marcela
Seinen, Tom
Shoaibi, Azza
Spotnitz, Matthew E.
Steyerberg, Ewout W.
Suchard, Marc A.
You, Seng Chan
Zhang, Lin
Zhou, Lili
Ryan, Patrick B.
Prieto-Alhambra, Daniel
Reps, Jenna M.
Rijnbeek, Peter R.
Article History
Received: 6 January 2021
Accepted: 3 January 2022
First Online: 30 January 2022
Declarations
:
: The manuscript uses secondary data and as such no human participants were involved in the study and informed consent was not necessary at any site.
: Not applicable.
: RDW, AM, CY, TDS, TF, JJ, CK, YR, AW, AA, MHO, MA, CA, EB, YHC, ID, MTFA, SFB, JAK, STL, FN, RWP, NP, TS, MS, EWS, SCY, LZ(Zhang), LZ(Zhou), report no conflicts of interest.MM reports grants from Department of Veteran Affairs, grants from National Institutes of Health, outside the submitted work; SLD reports grants from Anolinx, LLC, grants from Astellas Pharma, Inc., grants from AstraZeneca Pharmaceuticals LP, grants from Boehringer Ingelheim International GmbH, grants from Celgene Corporation, grants from Eli Lilly and Company, grants from Genentech Inc., grants from Genomic Health, Inc., grants from Gilead Sciences Inc., grants from GlaxoSmithKline PLC, grants from Innocrin Pharmaceuticals Inc., grants from Janssen Pharmaceuticals, Inc., grants from Kantar Health, grants from Myriad Genetic Laboratories, Inc., grants from Novartis International AG, grants from Parexel International Corporation, outside the submitted work; BK-H reports grants from Innovation Fund Denmark, grants from Novo Nordisk Foundation, during the conduct of the study; DPA reports grants and other from UCB Biopharma SRL, grants and other from Amgen, grants from Servier Laboratoires, outside the submitted work; DM reports grants from Wellcome Trust (Clinical Research Development Fellowship), grants from Chief Scientist Office (CSO), grants from Health Data Research UK (HDR-UK), grants from National Institute of Health Research (NIHR), outside the submitted work; AP-U reports grants from Fundacion Alfonso Martin Escudero, grants from Medical Research Council, outside the submitted work; GH reports grants from NIH National Library of Medicine, during the conduct of the study; grants from Janssen Research, outside the submitted work; JMR, PBR, AS, GR are employees of Janssen Research and Development and are shareholders of Johnson & Johnson. KK and CR report as employees of IQVIA. MR reports personal fees from Bayer Hispania, S.L., outside the submitted work; PLK and LZ are AbbVie employees. MAS reports grants from US National Institutes of Health, grants from IQVIA, personal fees from Janssen Research and Development, personal fees from Private Health Management, during the conduct of the study; PRR reports grants from Innovative Medicines Initiative, grants from Janssen Research and Development, during the conduct of the study; GM is a full-time employee of Janssen Latin America, outside the submitted work.